Rationale and design of randomized, double-blind trial evaluating the efficacy of single-dose HPV vaccine efficacy in women aged 18 to 30: The PRISMA trial.
Evidence from the Costa Rica HPV Vaccine Trial suggested that a single dose may provide durable protection in young adult women. Subsequent studies confirmed the non-inferiority of one vs. two doses of the main vaccines among young girls. Vaccination of older cohorts might accelerate cervical cancer elimination, especi...